CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma

Epithelial ovarian cancer (EOC) is the deadliest gynecological malignancy. EOC control remains difficult, and EOC patients show poor prognosis regarding metastasis and chemotherapy resistance. The aim of this study was to estimate the effect of CXCR4 knockdown-mediated reduction of cancer stem cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Zi, Dan, Li, Qing, Xu, Cheng-xiong, Zhou, Zhi-Wei, Song, Guan-Bin, Hu, Cheng-Bin, Wen, Fang, Yang, Han-Lin, Nie, Lei, Zhao, Xing, Tan, Jun, Zhou, Shu-Feng, He, Zhi-Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217704/
https://www.ncbi.nlm.nih.gov/pubmed/35681259
http://dx.doi.org/10.18632/aging.203241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217704/
https://www.ncbi.nlm.nih.gov/pubmed/35681259
http://dx.doi.org/10.18632/aging.203241

Ejemplares similares